Evidence map›Paper›PMID 30531295›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Brief Report: Pre-exposure Prophylaxis Awareness and Use Among Cisgender Women at a Sexually Transmitted Disease Clinic.

Julia R Raifman, Sheree R Schwartz, Collette D Sosnowy, Madeline C Montgomery, Alexi Almonte, Angela R Bazzi, Mari-Lynn Drainoni, Michael D Stein, Tiara C Willie, Amy S Nunn and 1 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Health Care Providers' Reported Barriers to Pre-Exposure Prophylaxis Initiation Among Cisgender Women.Health education & behavior : the official publication of the Society for Public Health Education · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julia R RaifmanDepartment of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA.
Sheree R SchwartzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Collette D SosnowyDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Madeline C MontgomeryDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Alexi AlmonteDepartment of Medicine, Brown University, Providence, RI.
Angela R BazziDepartment of Community Health Sciences, Boston University School of Public Health, Boston, MA.
Mari-Lynn DrainoniDepartment of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA.
Michael D SteinDepartment of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA.
Tiara C WillieDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Amy S NunnDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
Philip A ChanDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Characterizing the HIV pre-exposure prophylaxis care continuum for African American and Hispanic/Latino men who have sex with menR01MH114657 · NIMH · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW, NUNN, AMY STEWART · 2017 to 2021
$3.4M
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
A Structural Approach to Improving HIV Pre-Exposure Prophylaxis (PrEP) Implementation among High Risk MenK01MH116817 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAIFMAN, JULIA · 2018 to 2021
$639k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K01 DA043412NIMH NIH HHS K01 MH116817NIMH NIH HHS R01 MH114657NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

backgroundPre-exposure prophylaxis (PrEP) is highly effective in preventing HIV transmission. Cisgender women (cis-women) constitute only a small proportion of PrEP users in the United States despite accounting for 19% of new HIV infections in 2016.

settingThe Rhode Island Sexually Transmitted Diseases (STD) Clinic from 2013 to 2016.

methodsWe report on the demographic and behavioral characteristics of all HIV-negative, cis-women who presented to the Clinic and of those who met Centers for Disease Control and Prevention (CDC) indications for PrEP. In a logistic regression analysis, we evaluated PrEP awareness among cis-women by year and demographic characteristics. We compared PrEP awareness among cis-women with PrEP awareness among cisgender men who have sex with men and among cisgender men who inject drugs presenting to the Clinic.

resultsAmong 1431 HIV-negative cis-women, 84 (5.8%) met CDC indications for PrEP. PrEP awareness was significantly lower among Hispanic/Latina cis-women [11.0%; adjusted odds ratio (AOR): 0.46, 95% confidence interval (CI): 0.31 to 0.66] and non-Hispanic black cis-women (13.8%; AOR: 0.59, 95% CI: 0.39 to 0.89) relative to non-Hispanic white cis-women (20.7%). Men who have sex with men had significantly greater PrEP awareness (60.3%; AOR: 5.85, 95% CI: 3.35 to 10.23) than cis-women (22.9%). Only one woman reported PrEP use.

conclusionsTwo-thirds of HIV-negative cis-women presenting for HIV/sexually transmitted disease testing and meeting CDC indications for PrEP were unaware of PrEP, and only one woman reported ever using PrEP. There is a critical need for public health professionals and health care providers to increase PrEP awareness and use among cis-women at risk for HIV.

Indexed as

Pre-Exposure ProphylaxisAdultFemaleHealth EducationHealth Knowledge, Attitudes, PracticeHealth SurveysHumansMiddle AgedPatient Acceptance of Health CareSexual HealthSexually Transmitted DiseasesSexual PartnersSubstance Abuse, IntravenousUnited States

Identifiers

PMID30531295
PMCPMC6293982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.